Skip to main content

Ipilimumab Extends Survival in Melanoma : Median survival was about 10 months in patients who received the agent vs. 6.4 months without it.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Ipilimumab Extends Survival in Melanoma : Median survival was about 10 months in patients who received the agent vs. 6.4 months without it.

User login

Username

Password

Reset your password

Type	Lead	score